CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Funds and ETFs Chongqing Zhifei Biological Products Co., Ltd.
Equities
300122
CNE100000V20
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.83 CNY | +1.81% |
|
-13.98% | -43.00% |
ETFs positioned on Chongqing Zhifei Biological Products Co., Ltd.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.58% | 12 M€ | -16.71% | - | |
| 2.41% | 2 M€ | -16.59% | - | |
| 1.57% | 2 M€ | -14.14% | ||
| 0.23% | 35 M€ | -5.85% | - | |
| 0.07% | 11 M€ | +1.79% | ||
| 0.01% | 149 M€ | +2.17% | - | |
| 0.01% | 441 M€ | +4.60% | - | |
| 0.01% | 2,808 M€ | +5.90% | - | |
| 0.01% | 4 M€ | -4.41% | - | |
| 0.01% | 117 M€ | +1.11% | - | |
| 0.01% | 31 M€ | +3.50% | - | |
| 0.00% | 34 M€ | +2.14% | - | |
| 0.00% | 34 M€ | +6.71% | - | |
| 0.00% | 389 M€ | +6.83% | - | |
| 0.00% | 39 M€ | +3.67% | - | |
| 0.00% | 302 M€ | +3.80% | - | |
| 0.00% | 147 M€ | +4.88% | - |
Chongqing Zhifei Biological Products Co., Ltd. specializes in the research and development of vaccines for human use. The products include, in particular, bacterial vaccines for the prevention of meningitis, tuberculosis, rabies and influenza.
Sector
Pharmaceuticals
Calendar
18/06/2024
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
13
Last Close Price
34.83
CNY
Average target price
62.47
CNY
Spread / Average Target
+79.35%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -43.00% | 11.51B | |
| -4.66% | 86.13B | |
| +1.32% | 39.82B | |
| -19.27% | 30.42B | |
| +57.86% | 25.23B | |
| -16.09% | 15.36B | |
| -9.14% | 11.95B | |
| -17.69% | 11.6B | |
| +5.24% | 8.71B | |
| -8.42% | 8.12B |
- Stock Market
- Equities
- 300122 Stock
- Funds and ETFs Chongqing Zhifei Biological Products Co., Ltd.
